Reader Comments

Post a new comment on this article

Must be read by public and private managers allocating drug R&D resources

Posted by ManuelD on 18 Jan 2011 at 00:30 GMT

Patients, health practitioners and medical researchers greatly benefit and will benefit from the progress of genomic. However, as very well stated by the authors of this Column entitled "Being More Realistic about the Public Health Impact of Genomic Medicine", it is also critical to assess the real impact of genetic and genomic in public health. Such that the other areas of medical research receive the support they deserve.

Competing interests declared: I am a research scientist in a Drug R&D private organization.